account_balance
Investment manager · 13F filer · SEC CIK 1757283
Andera Partners
Reported value$206Mas of Jun 30, 2026
Positions8 1 new, 0 sold out
Top 10 weight100.0%KMTS alone is 34%
FiledJul 2222 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 8 stocks.
KMTSKestra Med Technologies Ltd
33.6%
MLYSMineralys Therapeutics Inc
20.8%
AVLNAvalyn Pharmaceuticals Inc
14.8%New
AGMBAgomab Therapeutics NV
9.7%
EVMNEvommune Inc
9.0%Trimmed −27%
IVAInventiva SA
6.7%Added +100%
ABVXAbivax SA
5.0%
KMTSKestra Med Technologies Ltd
33.6%
MLYSMineralys Therapeutics Inc
20.8%
AVLN14.8%AGMBAgomab Therapeutics NV
9.7%
EVMNEvommune Inc
9.0%Trimmed −27%
IVA6.7%ABVX5.0%Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 8 as a list
What changed